These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 6168277

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Enhanced cytotoxicity of melphalan by prolonged exposure to nitroimidazoles: the role of endogenous thiols.
    Roizin-Towle L, Hall EJ, Flynn M, Biaglow JE, Varnes ME.
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):757-60. PubMed ID: 7107410
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Studies on the mechanism of chemosensitization by misonidazole in vitro.
    Taylor YC, Bump EA, Brown JM.
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):705-8. PubMed ID: 7107402
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Misonidazole increases the toxicity of BCNU for hypoxic cells.
    Tannock I, Guttman P.
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):663-6. PubMed ID: 7107395
    [Abstract] [Full Text] [Related]

  • 11. Mechanism of sensitization of Chinese hamster ovary cells to melphalan by hypoxic treatment with misonidazole.
    Taylor YC, Evans JW, Brown JM.
    Cancer Res; 1983 Jul; 43(7):3175-81. PubMed ID: 6850627
    [No Abstract] [Full Text] [Related]

  • 12. Selective enhancement of hypoxic cell killing by melphalan via thiol depletion: in vitro studies with hypoxic cell sensitizers and buthionine sulfoximine.
    Roizin-Towle L.
    J Natl Cancer Inst; 1985 Jan; 74(1):151-7. PubMed ID: 3155814
    [Abstract] [Full Text] [Related]

  • 13. Sulphydryls, ascorbate and oxygen as modifiers of the toxicity and metabolism of misonidazole in vitro.
    Taylor YC, Rauth AM.
    Br J Cancer; 1980 Jun; 41(6):892-900. PubMed ID: 7426314
    [Abstract] [Full Text] [Related]

  • 14. Oxygen dependence for chemosensitization by misonidazole.
    Roizin-Towle L, Hall EJ, Pirro JP.
    Br J Cancer; 1986 Dec; 54(6):919-24. PubMed ID: 3801287
    [Abstract] [Full Text] [Related]

  • 15. Chemosensitization of mouse tumors by misonidazole.
    Randhawa VS, Stewart FA, Denekamp J.
    Int J Radiat Oncol Biol Phys; 1982 Dec; 8(3-4):671-4. PubMed ID: 7107397
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of X-ray-induced potentially lethal damage (PLD) repair in aerobic plateau-phase Chinese hamster cells by misonidazole.
    Brown DM, Dionet C, Brown JM.
    Radiat Res; 1984 Jan; 97(1):162-70. PubMed ID: 6229806
    [Abstract] [Full Text] [Related]

  • 18. Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.
    Twentyman P, Workman P.
    Br J Cancer; 1982 Mar; 45(3):447-55. PubMed ID: 7073938
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the cytotoxicity of 5-thio-D-glucose and misonidazole on hypoxic cells in vitro.
    Song CW, Lee CK, Rhee JG, Levitt SH.
    Int J Radiat Oncol Biol Phys; 1982 Mar; 8(3-4):749-52. PubMed ID: 6809705
    [Abstract] [Full Text] [Related]

  • 20. Enhancement of cytotoxic drugs by misonidazole (MISO) in Lewis lung tumors of different sizes, and mouse bone marrow.
    Spooner D, Peacock JH, Stephens TC.
    Int J Radiat Oncol Biol Phys; 1982 Mar; 8(3-4):643-6. PubMed ID: 7107390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.